Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.
作者信息
Durando Paolo, Faust Saul N, Torres Antoni
机构信息
Department of Health Sciences, School of Medical and Pharmaceutical Sciences, Postgraduate School in Occupational Medicine, University of Genoa and Medical Surveillance Unit for Health Care Workers, Occupational Medicine Unit, IRCCS San Martino Hospital, Largo R. Benzi 10, 16132 Genoa, Italy.
NIHR Wellcome Trust Clinical Research Facility, University of Southampton, C Level, West Wing, Mailpoint 218, UK ; University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton SO16 6YD, UK.
出版信息
J Immunol Res. 2015;2015:934504. doi: 10.1155/2015/934504. Epub 2015 Aug 18.
Abstract
摘要
相似文献
1
Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.
J Immunol Res. 2015;2015:934504. doi: 10.1155/2015/934504. Epub 2015 Aug 18.
2
[A new vaccine concept: polysaccharide conjugate vaccines].
Ann Pharm Fr. 1999 May;57(3):223-31.
3
NMR assays for carbohydrate-based vaccines.
J Pharm Biomed Anal. 2005 Aug 10;38(5):840-50. doi: 10.1016/j.jpba.2005.01.044. Epub 2005 Apr 13.
4
Challenges in immunisation against bacterial infection in children.
Early Hum Dev. 2010 Nov;86(11):695-701. doi: 10.1016/j.earlhumdev.2010.08.010. Epub 2010 Sep 19.
5
T-cell dependent and T-cell independent antibody response to bacterial polysaccharides in patients with IgG2 deficiency.
Immunodeficiency. 1993;4(1-4):59-61.
6
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Expert Rev Vaccines. 2011 May;10(5):673-84. doi: 10.1586/erv.11.14.
7
The promise of conjugate vaccines for Africa.
Vaccine. 2007 Sep 3;25 Suppl 1:A108-10. doi: 10.1016/j.vaccine.2007.05.001. Epub 2007 May 21.
8
Bacterial polysaccharide-protein conjugate vaccines.
Br Med Bull. 2004 Aug 31;70:1-14. doi: 10.1093/bmb/ldh021. Print 2004.
9
[Fimbriae as a pathologic factor of bacteria and a carrier in conjugate vaccines].
Postepy Hig Med Dosw. 2000;54(6):727-47.
10
Conjugate vaccines against group B Streptococcus types IV and VII.
J Infect Dis. 2002 Jul 1;186(1):123-6. doi: 10.1086/341073. Epub 2002 Jun 14.
引用本文的文献
1
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2203634. doi: 10.1080/21645515.2023.2203634.
2
Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020529. doi: 10.1080/21645515.2021.2020529. Epub 2022 Jan 27.
3
Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
Molecules. 2018 Jun 29;23(7):1583. doi: 10.3390/molecules23071583.
本文引用的文献
1
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
2
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
3
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):19-31. doi: 10.1007/s10096-014-2208-6. Epub 2014 Aug 23.
4
The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review.
BMC Public Health. 2013;13 Suppl 3(Suppl 3):S21. doi: 10.1186/1471-2458-13-S3-S21. Epub 2013 Sep 17.
5
Pneumococcal infection in adults: burden of disease.
Clin Microbiol Infect. 2014 May;20 Suppl 5:45-51. doi: 10.1111/1469-0691.12461. Epub 2014 Jan 24.
6
Haemophilus influenzae serotype a as a cause of serious invasive infections.
Lancet Infect Dis. 2014 Jan;14(1):70-82. doi: 10.1016/S1473-3099(13)70170-1. Epub 2013 Nov 20.
7
Advances towards the prevention of meningococcal B disease: a multidimensional story.
J Infect. 2014 Jan;68 Suppl 1:S76-82. doi: 10.1016/j.jinf.2013.09.026. Epub 2013 Oct 16.
8
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320.
9
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
N Engl J Med. 2013 Jul 11;369(2):155-63. doi: 10.1056/NEJMoa1209165.
10
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.
Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11.
Zotero 插件